ADVERTISEMENT

ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20

ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20

A technician holds an agar plate containing bacteria cell culture at a Bugworks Research India Ltd. laboratory in Bengaluru, India. (Photographer: Samyukta Lakshmi/Bloomberg)  
A technician holds an agar plate containing bacteria cell culture at a Bugworks Research India Ltd. laboratory in Bengaluru, India. (Photographer: Samyukta Lakshmi/Bloomberg)  
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More